A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer

Acta Oncol. 2008;47(1):152-3. doi: 10.1080/02841860701418853.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Small Cell / drug therapy*
  • Docetaxel
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Recombinant Proteins
  • Taxoids / administration & dosage
  • Topotecan / administration & dosage
  • Treatment Failure

Substances

  • Recombinant Proteins
  • Taxoids
  • Granulocyte Colony-Stimulating Factor
  • Docetaxel
  • Topotecan
  • Filgrastim